Table 2.
All participants' ERP P1 mean latencies [mean (SD), ms] and mean amplitudes [mean (SD), μV] *.
| Scalp regions | IAG | NCG | ||||||
|---|---|---|---|---|---|---|---|---|
| Compatible trials | Incompatible trials | Compatible trials | Incompatible trials | |||||
| Latencies | Amplitudes | Latencies | Amplitudes | Latencies | Amplitudes | Latencies | Amplitudes | |
| Frontal lobe | 136 (10) | 3.5 (0.4) | 133 (10) | 3.4 (0.4) | 135 (10) | 3.3 (0.4) | 139 (12) | 3.5 (0.3) |
| Parietal lobe | 130 (15) | 3.5 (0.5) | 134 (9) | 3.5 (0.6) | 138 (11) | 3.5 (0.5) | 136 (11) | 3.7 (0.6) |
| Central lobe | 137 (12) | 3.6 (0.5) | 136 (16) | 3.3 (0.6) | 141 (12) | 3.6 (0.4) | 133 (11) | 3.6 (0.6) |
| Temporal lobe (T3) | 130 (15) | 3.4 (0.5) | 140 (13) | 3.5 (0.5) | 134 (12) | 3.4 (0.5) | 136 (10) | 3.3 (0.8) |
| Temporal lobe (T4) | 135 (10) | 3.5 (0.4) | 135 (10) | 3.6 (0.5) | 133 (13) | 3.5 (0.6) | 135 (11) | 3.7 (0.6) |
| Occipital lobe | 134 (11) | 3.6 (0.7) | 132 (11) | 3.5 (0.6) | 138 (10) | 3.3 (0.5) | 132 (12) | 3.6 (0.6) |
*
The sum of all corresponding scalp region latencies and amplitudes divided by the number of electrode sites are the mean latencies and mean amplitudes, respectively.